Optimized organoid culture protocol for primary non-small cell lung cancer and predicting individual drug response

Patient-derived organoids (PDOs) provide experimentally tractable models of non-small cell lung cancer (NSCLC), but their use is limited by variable establishment efficiency, overgrowth by normal airway epithelium, and incompletely standardized culture conditions. We developed an optimized, subtype-adapted NSCLC PDO culture system based on conditioned medium from irradiated Swiss 3T3-J2 fibroblasts (iJ2-CM), combined with the ROCK inhibitor Y-27632 and the TGF-β receptor inhibitor A83-01. Systematic cytokine screening identified insulin-like growth factor-1 (IGF-1) and epidermal growth factor (EGF) as potent enhancers of the proliferation and viability of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) organoids, respectively. Matched histology and whole-exome sequencing demonstrated retention of lineage-associated features and tumor-associated genomic alterations. Importantly, this platform supports multiple downstream applications, including scalable drug screening and autologous immune cell co-culture assays, enabling the prediction of patient-specific responses to chemotherapy, targeted therapies, and immunotherapies. Collectively, this study establishes a physiologically relevant, subtype-tailored, and experimentally scalable NSCLC organoid platform with potential for mechanistic investigation, precision drug testing, and translational cancer research.

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2026-11-19
DOI
https://doi.org/10.1186/s12943-026-02831-2
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Optimized organoid culture protocol for primary non-small cell lung cancer and predicting individual drug response

Kenneth K.W. To, Liwu Fu, Xu Zhang, Xin Su et al.
Molecular Cancer
Cancer Cells and Metastasis
article

Optimized organoid culture protocol for primary non-small cell lung cancer and predicting individual drug response

Kenneth K.W. To, Liwu Fu, Xu Zhang, Xin Su, Chufeng Zeng, Can Pan, Sijia Li, Shuangli Zhu, Xueping Wang, Yuelu Lan, Jinsui Li, 曹张琦, Kai Fu, Fang Wang, Yingfang Fan
article en

Abstract

Patient-derived organoids (PDOs) provide experimentally tractable models of non-small cell lung cancer (NSCLC), but their use is limited by variable establishment efficiency, overgrowth by normal airway epithelium, and incompletely standardized culture conditions. We developed an optimized, subtype-adapted NSCLC PDO culture system based on conditioned medium from irradiated Swiss 3T3-J2 fibroblasts (iJ2-CM), combined with the ROCK inhibitor Y-27632 and the TGF-β receptor inhibitor A83-01. Systematic cytokine screening identified insulin-like growth factor-1 (IGF-1) and epidermal growth factor (EGF) as potent enhancers of the proliferation and viability of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) organoids, respectively. Matched histology and whole-exome sequencing demonstrated retention of lineage-associated features and tumor-associated genomic alterations. Importantly, this platform supports multiple downstream applications, including scalable drug screening and autologous immune cell co-culture assays, enabling the prediction of patient-specific responses to chemotherapy, targeted therapies, and immunotherapies. Collectively, this study establishes a physiologically relevant, subtype-tailored, and experimentally scalable NSCLC organoid platform with potential for mechanistic investigation, precision drug testing, and translational cancer research.

Molecular Cancer
Sun Yat-sen University (CN), Chinese University of Hong Kong (HK), Third Affiliated Hospital of Southern Medical University (CN), Sun Yat-sen University Cancer Center (CN), State Key Laboratory of Oncology in South China (CN)
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon